Sciwind Biosciences APAC CO Pty. Ltd. Report issue

For profit Phase 2
Founded: Hangzhou China (2017)

Organization Overview

First Clinical Trial
2020
NCT04389775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hangzhou Sciwind Biosciences Co., Ltd. | Sciwind Biosciences APAC CO Pty. Ltd. | Sciwind Biosciences USA Co., Ltd